New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era
Diabetes, Metabolic Syndrome and Obesity · 2026-09 · Volume 19 · 1-18
DOI: 10.2147/dmso.s622389 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-09. Verfasst von Xiao Ke Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a major microvascular complication of diabetes and the leading cause of end-stage renal disease worldwide. Accumulating evidence identifies mitochondrial dysfunction as a central driver of DKD progression by linking metabolic reprogramming, oxidative stress, and inflammatory responses. Recent advances in spatial omics, genomics, transcriptomics, proteomics, metabolomics, and microbiome analyses have enabled the characterization of cell-specific and dynamic alterations in mitochondrial function and their interactions with the renal microenvironment. Integrative analyses across these molecular layers have revealed key mechanisms involving mitochondrial quality control, metabolic reprogramming, and inflammatory signaling, while identifying potential biomarkers and therapeutic targets. Furthermore, these approaches have provided mechanistic insights into the renoprotective effects of conventional therapies and bioactive compounds from traditional Chinese medicine. This integrative review synthesizes current evidence to clarify the role of mitochondrial dysfunction in DKD pathogenesis and discusses emerging opportunities for biomarker discovery and precision therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
ORCID-Profile: Xiao Lan Zhou, Wen Rui Xia
Zitieren
APA
Liu, X. K., Zhou, X. L., & Xia, W. R. (2026). New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-18. https://doi.org/10.2147/dmso.s622389
Vancouver
Liu XK, Zhou XL, Xia WR. New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-18. doi:10.2147/dmso.s622389
BibTeX
@article{Liu2026,
author = {Liu, Xiao Ke and Zhou, Xiao Lan and Xia, Wen Rui},
title = {New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--18},
doi = {10.2147/dmso.s622389}
}
EUVIMED